According to the 5th revision of World Health Organization (WHO) of central nervous system tumors classification, gliosarcoma is a malignant tumor grade 4 and is the rarest and aggressive subtype of isocitrate dehydrogenase (IDH) wild-type glioblastoma. The gene discussed is IDH3A; the disease is central nervous system neoplasm.